These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
252 related articles for article (PubMed ID: 30370347)
1. Generating antitumor immunity by targeted radiation therapy: Role of dose and fractionation. Ko EC; Benjamin KT; Formenti SC Adv Radiat Oncol; 2018; 3(4):486-493. PubMed ID: 30370347 [TBL] [Abstract][Full Text] [Related]
2. Awakening the immune system with radiation: Optimal dose and fractionation. Gandhi SJ; Minn AJ; Vonderheide RH; Wherry EJ; Hahn SM; Maity A Cancer Lett; 2015 Nov; 368(2):185-90. PubMed ID: 25799953 [TBL] [Abstract][Full Text] [Related]
3. Single High-Dose Irradiation-Induced iRhom2 Upregulation Promotes Macrophage Antitumor Activity Through cGAS/STING Signaling. Zhao X; Wang B; Zhuang Y; Du S; Zeng Z Int J Radiat Oncol Biol Phys; 2023 Aug; 116(5):1150-1162. PubMed ID: 36792017 [TBL] [Abstract][Full Text] [Related]
4. Regulatory T Cells Shape the Differential Impact of Radiation Dose-Fractionation Schedules on Host Innate and Adaptive Antitumor Immune Defenses. Sia J; Hagekyriakou J; Chindris I; Albarakati H; Leong T; Schlenker R; Keam SP; Williams SG; Neeson PJ; Johnstone RW; Haynes NM Int J Radiat Oncol Biol Phys; 2021 Oct; 111(2):502-514. PubMed ID: 34023423 [TBL] [Abstract][Full Text] [Related]
5. Personalized Ultrafractionated Stereotactic Adaptive Radiotherapy (PULSAR) in Preclinical Models Enhances Single-Agent Immune Checkpoint Blockade. Moore C; Hsu CC; Chen WM; Chen BPC; Han C; Story M; Aguilera T; Pop LM; Hannan R; Fu YX; Saha D; Timmerman R Int J Radiat Oncol Biol Phys; 2021 Aug; 110(5):1306-1316. PubMed ID: 33794306 [TBL] [Abstract][Full Text] [Related]
6. Radiation as an immunological adjuvant: current evidence on dose and fractionation. Demaria S; Formenti SC Front Oncol; 2012; 2():153. PubMed ID: 23112958 [TBL] [Abstract][Full Text] [Related]
7. Radiation dose and fraction in immunotherapy: one-size regimen does not fit all settings, so how does one choose? Demaria S; Guha C; Schoenfeld J; Morris Z; Monjazeb A; Sikora A; Crittenden M; Shiao S; Khleif S; Gupta S; Formenti SC; Vikram B; Coleman CN; Ahmed MM J Immunother Cancer; 2021 Apr; 9(4):. PubMed ID: 33827904 [TBL] [Abstract][Full Text] [Related]
15. Synergistic effects of anti-PDL-1 with ablative radiation comparing to other regimens with same biological effect dose based on different immunogenic response. Alinezhad M; Bakhshandeh M; Rostami E; Alimohamadi R; Mosaffa N; Jalali SA PLoS One; 2020; 15(4):e0231507. PubMed ID: 32287292 [TBL] [Abstract][Full Text] [Related]
16. Congress of Neurological Surgeons Systematic Review and Evidence-Based Guidelines on the Role of Whole Brain Radiation Therapy in Adults With Newly Diagnosed Metastatic Brain Tumors. Gaspar LE; Prabhu RS; Hdeib A; McCracken DJ; Lasker GF; McDermott MW; Kalkanis SN; Olson JJ Neurosurgery; 2019 Mar; 84(3):E159-E162. PubMed ID: 30629211 [TBL] [Abstract][Full Text] [Related]
17. Practice patterns for postoperative radiation therapy in patients with metastases to the long bones: a survey of the Japanese Radiation Oncology Study Group. Kubota H; Nakamura N; Shikama N; Tonari A; Wada H; Harada H; Nagakura H; Heianna J; Ito K; Nozaki M; Tago M; Fushiki M; Uchida N; Araki N; Sekii S; Kosugi T; Takahashi T; Kawamoto T; Saito T; Yamada K J Radiat Res; 2021 Mar; 62(2):356-363. PubMed ID: 33454759 [TBL] [Abstract][Full Text] [Related]
18. Stereotactic Body Radiation Therapy for Nonspine Bone Metastases: International Practice Patterns to Guide Treatment Planning. Nguyen TK; Sahgal A; Dagan R; Eppinga W; Guckenberger M; Kim JH; Lo SS; Redmond KJ; Siva S; Stish BJ; Tseng CL Pract Radiat Oncol; 2020; 10(6):e452-e460. PubMed ID: 32171852 [TBL] [Abstract][Full Text] [Related]
19. Radiation therapy to enhance tumor immunotherapy: a novel application for an established modality. Ko EC; Formenti SC Int J Radiat Biol; 2019 Jul; 95(7):936-939. PubMed ID: 31120369 [No Abstract] [Full Text] [Related]
20. Maximizing Tumor Control and Limiting Complications With Stereotactic Body Radiation Therapy for Pancreatic Cancer. Mahadevan A; Moningi S; Grimm J; Li XA; Forster KM; Palta M; Prior P; Goodman KA; Narang A; Heron DE; Lo SS; Urbanic J; Herman JM Int J Radiat Oncol Biol Phys; 2021 May; 110(1):206-216. PubMed ID: 33358561 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]